Details of the Drug Reposition

General Information of This Drug (ID: DMQXU4C)

Drug Name
Anti-CD19-CAR vector-transduced T cells   DMQXU4C
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Mantle cell lymphoma DISFREOV 2A85.5 Phase 1/2 [1]
B-cell non-hodgkin lymphoma DISUB5FB 2B33.5 Phase 1/2 [1]
------------------------------------------------------------------------------------
3 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Clinical trial [2]
Diffuse large B-cell lymphoma DISSACK3 2A81 Clinical trial [2]
B-cell chronic lymphocytic leukaemia DISNHN2M 2A82.00 Clinical trial [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02081937) CART-19 Immunotherapy in Mantle Cell Lymphoma
2 ClinicalTrials.gov (NCT01864889) Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19